Vicus Capital Merck & Co., Inc. Transaction History

Vicus Capital

$1.1 Billion
Q2 2024

A detailed history of Vicus Capital transactions in Merck & Co., Inc. stock. As of the latest transaction made, Vicus Capital holds 9,042 shares of MRK stock, worth $996,247. This represents 0.1% of its overall portfolio holdings.

Number of Shares

9,042

Previous 8,627 4.81%

Holding current value

$996,247

Previous $1.14 Million 1.67%

% of portfolio

0.1%

Previous 0.1%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$123.8 - $132.96 $51,377 - $55,178	415 Added 4.81%	9,042 $1.12 Million
Q1 2024 Apr 17, 2024	BUY	$113.24 - $131.95 $257,281 - $299,790	2,272 Added 35.75%	8,627 $1.14 Million
Q4 2023 Feb 01, 2024	SELL	$100.18 - $109.02 $281,505 - $306,346	-2,810 Reduced 30.66%	6,355 $692,000
Q3 2023 Oct 23, 2023	BUY	$102.95 - $114.33 $244,403 - $271,419	2,374 Added 34.96%	9,165 $943,000
Q2 2023 Aug 17, 2023	SELL	$108.61 - $118.38 $39,534 - $43,090	-364 Reduced 5.09%	6,791 $783,000
Q1 2023 May 02, 2023	SELL	$102.94 - $114.86 $2,367 - $2,641	-23 Reduced 0.32%	7,155 $761,000
Q4 2022 Feb 15, 2023	SELL	$87.44 - $112.11 $13,378 - $17,152	-153 Reduced 2.09%	7,178 $796,000
Q3 2022 Nov 08, 2022	SELL	$84.53 - $94.96 $11,665 - $13,104	-138 Reduced 1.85%	7,331 $631,000
Q2 2022 Aug 10, 2022	SELL	$83.49 - $94.64 $39,574 - $44,859	-474 Reduced 5.97%	7,469 $681,000
Q1 2022 May 11, 2022	BUY	$73.51 - $82.4 $95,415 - $106,955	1,298 Added 19.53%	7,943 $652,000
Q4 2021 Feb 10, 2022	BUY	$72.28 - $90.54 $480,300 - $601,638	6,645 New	6,645 $560,000
Q2 2021 Aug 10, 2021	SELL	$70.31 - $77.77 $483,451 - $534,746	-6,876 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$68.86 - $81.11 $8,194 - $9,652	119 Added 1.76%	6,876 $530,000
Q4 2020 Feb 01, 2021	SELL	$71.77 - $79.65 $13,492 - $14,974	-188 Reduced 2.71%	6,757 $553,000
Q3 2020 Nov 12, 2020	BUY	$73.18 - $82.95 $27,003 - $30,608	369 Added 5.61%	6,945 $576,000
Q2 2020 Aug 03, 2020	SELL	$70.42 - $80.13 $87,672 - $99,761	-1,245 Reduced 15.92%	6,576 $509,000
Q1 2020 May 07, 2020	SELL	$63.36 - $87.82 $11,341 - $15,719	-179 Reduced 2.24%	7,821 $602,000
Q4 2019 Feb 04, 2020	SELL	$77.58 - $87.54 $822,580 - $928,186	-10,603 Reduced 57.0%	8,000 $728,000
Q3 2019 Nov 18, 2019	BUY	$76.08 - $82.93 $353,163 - $384,961	4,642 Added 33.25%	18,603 $1.57 Million
Q2 2019 Aug 08, 2019	SELL	$69.84 - $81.59 $9,218 - $10,769	-132 Reduced 0.94%	13,961 $1.17 Million
Q1 2019 May 02, 2019	SELL	$69.58 - $79.36 $5,009 - $5,713	-72 Reduced 0.51%	14,093 $1.17 Million
Q4 2018 Feb 07, 2019	BUY	$65.24 - $75.71 $17,680 - $20,517	271 Added 1.95%	14,165 $1.08 Million
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $18,114 - $21,301	-314 Reduced 2.21%	13,894 $986,000
Q2 2018 Aug 02, 2018	SELL	$50.83 - $59.72 $19,315 - $22,693	-380 Reduced 2.6%	14,208 $862,000
Q1 2018 May 07, 2018	SELL	$50.96 - $59.23 $33,684 - $39,151	-661 Reduced 4.33%	14,588 $795,000
Q4 2017 Jan 25, 2018	BUY	$51.62 - $61.64 $21,680 - $25,888	420 Added 2.83%	15,249 $858,000
Q3 2017 Oct 27, 2017	BUY	$58.67 - $63.13 $870,017 - $936,154	14,829	14,829 $950,000

Others Institutions Holding MRK

# of Institutions

3,828

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $279B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vicus Capital, based on Form 13F filings with the SEC.

News

Stay updated on Vicus Capital with notifications on news.

Account